Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-02

AUTHORS

Andrew Dodson, David Okonji, Laura Assersohn, Anne Rigg, Amna Sheri, Nick Turner, Ian Smith, Marina Parton, Mitch Dowsett

ABSTRACT

PURPOSE: Oncotype DX, a gene expression assay widely employed to aid decision making on adjuvant chemotherapy use in patients with primary oestrogen receptor-positive (ER+) breast cancer, produces a recurrence score (RS) related to distant disease recurrence (DR) risk (RS%). In node-negative patients, RS can be integrated with clinicopathological parameters to derive RS-pathology-clinical (RSPC) that improves prognostic accuracy. METHODS: Data were collected on patients having clinically indicated tests with an intermediate clinical risk of distant recurrence, and for whom the decision to prescribe chemotherapy remained unclear. Correlation between RS% and RSPC scores was examined. An agreement table was constructed using risk-categorised data. Association between RS%-derived categorical risk assignments and treatment recommendation was evaluated. RESULTS: Data on 171 tests (168 patients) were available. Median DR risk by RS% was 11% (range 3-34%), by RSPC it was 15% (range 4-63%). Correlation between RS% and RSPC was 0.702 (p < 0.001). RS% classified 57.3% of cases as low-, 32.2% intermediate- and 10.5% high-risk for DR; by RSPC proportions were 33.9, 35.7, and 30.4%, respectively. The number of patients receiving chemotherapy recommendations was: 14/87 (16.1%) categorised as low-risk by RS%, 27/49 (55.1%) as intermediate-risk and 12/13 (92.3%) as high-risk. Of 149 patients recommended for endocrine treatment alone, 28 (18.8%) were categorised by RS% as low-risk but by RSPC as intermediate- or high-risk. CONCLUSIONS: In this group of patients, RSPC assessed fewer patients as low-risk and more as high-risk than did RS%. The discordances between the scores indicate that RSPC estimates of risk should be considered when selecting patients for endocrine therapy alone. More... »

PAGES

249-258

References to SciGraph publications

  • 1987-12. Confirmation of a prognostic index in primary breast cancer in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10549-017-4514-z

    DOI

    http://dx.doi.org/10.1007/s10549-017-4514-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1092649506

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29128896


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents, Hormonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms, Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chemotherapy, Adjuvant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Profiling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Testing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Incidence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mastectomy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Recurrence, Local", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Patient Selection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Predictive Value of Tests", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Estrogen", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Assessment", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "United Kingdom", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute of Cancer Research", 
              "id": "https://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK", 
                "Institute of Cancer Research, 123 Old Brompton Road, SW7 3RP, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dodson", 
            "givenName": "Andrew", 
            "id": "sg:person.0627311067.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627311067.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Marsden NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Okonji", 
            "givenName": "David", 
            "id": "sg:person.010725012037.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725012037.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "St George\u2019s University Hospitals NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.451349.e", 
              "name": [
                "St George\u2019s University Hospitals NHS Foundation Trust, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Assersohn", 
            "givenName": "Laura", 
            "id": "sg:person.0605365262.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605365262.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "National Health Service", 
              "id": "https://www.grid.ac/institutes/grid.451052.7", 
              "name": [
                "Guy\u2019s and St Thomas\u2019 Hospitals NHS Foundation Trust, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rigg", 
            "givenName": "Anne", 
            "id": "sg:person.011612374617.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011612374617.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Free Hospital", 
              "id": "https://www.grid.ac/institutes/grid.426108.9", 
              "name": [
                "Royal Free London Hospitals NHS Foundation Trust, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sheri", 
            "givenName": "Amna", 
            "id": "sg:person.0775270405.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775270405.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Marsden NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Turner", 
            "givenName": "Nick", 
            "id": "sg:person.012110012351.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012110012351.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Marsden NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Smith", 
            "givenName": "Ian", 
            "id": "sg:person.016301514162.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Marsden NHS Foundation Trust", 
              "id": "https://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Parton", 
            "givenName": "Marina", 
            "id": "sg:person.0735065012.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735065012.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Cancer Research", 
              "id": "https://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK", 
                "Institute of Cancer Research, 123 Old Brompton Road, SW7 3RP, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dowsett", 
            "givenName": "Mitch", 
            "id": "sg:person.015776405257.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015776405257.84"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1200/jco.2009.24.4798", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000489684"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(09)70314-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011515750"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2005.04.7985", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011750427"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(11)61625-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016340431"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa041588", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022156409"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/annonc/mdv221", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036102989"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa1510764", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036616787"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(14)61396-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046101168"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1987.230", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047698959", 
              "https://doi.org/10.1038/bjc.1987.230"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1987.230", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047698959", 
              "https://doi.org/10.1038/bjc.1987.230"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2011.35.3714", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049665380"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.clbc.2015.09.008", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049693612"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1080732988", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2017.74.0472", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1090577469"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-02", 
        "datePublishedReg": "2018-02-01", 
        "description": "PURPOSE: Oncotype DX, a gene expression assay widely employed to aid decision making on adjuvant chemotherapy use in patients with primary oestrogen receptor-positive (ER+) breast cancer, produces a recurrence score (RS) related to distant disease recurrence (DR) risk (RS%). In node-negative patients, RS can be integrated with clinicopathological parameters to derive RS-pathology-clinical (RSPC) that improves prognostic accuracy.\nMETHODS: Data were collected on patients having clinically indicated tests with an intermediate clinical risk of distant recurrence, and for whom the decision to prescribe chemotherapy remained unclear. Correlation between RS% and RSPC scores was examined. An agreement table was constructed using risk-categorised data. Association between RS%-derived categorical risk assignments and treatment recommendation was evaluated.\nRESULTS: Data on 171 tests (168 patients) were available. Median DR risk by RS% was 11% (range 3-34%), by RSPC it was 15% (range 4-63%). Correlation between RS% and RSPC was 0.702 (p\u00a0<\u00a00.001). RS% classified 57.3% of cases as low-, 32.2% intermediate- and 10.5% high-risk for DR; by RSPC proportions were 33.9, 35.7, and 30.4%, respectively. The number of patients receiving chemotherapy recommendations was: 14/87 (16.1%) categorised as low-risk by RS%, 27/49 (55.1%) as intermediate-risk and 12/13 (92.3%) as high-risk. Of 149 patients recommended for endocrine treatment alone, 28 (18.8%) were categorised by RS% as low-risk but by RSPC as intermediate- or high-risk.\nCONCLUSIONS: In this group of patients, RSPC assessed fewer patients as low-risk and more as high-risk than did RS%. The discordances between the scores indicate that RSPC estimates of risk should be considered when selecting patients for endocrine therapy alone.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s10549-017-4514-z", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1092777", 
            "issn": [
              "0167-6806", 
              "1573-7217"
            ], 
            "name": "Breast Cancer Research and Treatment", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "168"
          }
        ], 
        "name": "Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer", 
        "pagination": "249-258", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "d5109efecab0f6c40db614ced9de37ad6fb89c4d8c88b96b5f0eab2243002ac4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29128896"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "8111104"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10549-017-4514-z"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1092649506"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10549-017-4514-z", 
          "https://app.dimensions.ai/details/publication/pub.1092649506"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87088_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs10549-017-4514-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-017-4514-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-017-4514-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-017-4514-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-017-4514-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    265 TRIPLES      21 PREDICATES      64 URIs      43 LITERALS      31 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10549-017-4514-z schema:about N000e9de1a36e45adb827a456419f1925
    2 N0ddb03abfc4243e190998ab598f18761
    3 N145be29eaa2b4ebf8c60241438ebf484
    4 N221bff9ac07a413f8f7c3398f1dffe68
    5 N314ae4b124a545bfad6383ba3d520c4a
    6 N389ff044fa2c4d13ab4e15c069135fd4
    7 N464edc2459034a779eb7664f8690397e
    8 N4f37cc5d091f471c850f447da5eebaf8
    9 N6a71070520e74875bb397b004e7f50ca
    10 N6b5e3279dea04451ad4116f2bce1a711
    11 N85a77888f9eb4b5eb9498a907344102d
    12 N87cb59c54758466c8ce94b6594dabe3c
    13 N946afd739d8443e5a9d7475eca42a17f
    14 N98a3488a7d3748e1aedbed63167790b8
    15 N9db29da632c04d198c9484d26a4f1c66
    16 N9f7e4091bc614df58dc69523584d4b72
    17 Na1ed3dfa373346b390c0aa20957bdd2d
    18 Nb373b4fccd2b43119d7de548832e683b
    19 Nb76cfaeef7cc45edb0dbb6c1b64c038f
    20 Nc86a3a291ba942f38d4b98f05b4e8f4b
    21 Nfa564d6a22b6419881102e9884b2a952
    22 Nff22ef2194cf489b9d9ef945970663de
    23 anzsrc-for:11
    24 anzsrc-for:1112
    25 schema:author Ne254aff17e31419e861bba97e8ca7c08
    26 schema:citation sg:pub.10.1038/bjc.1987.230
    27 https://app.dimensions.ai/details/publication/pub.1080732988
    28 https://doi.org/10.1016/j.clbc.2015.09.008
    29 https://doi.org/10.1016/s0140-6736(11)61625-5
    30 https://doi.org/10.1016/s0140-6736(14)61396-9
    31 https://doi.org/10.1016/s1470-2045(09)70314-6
    32 https://doi.org/10.1056/nejmoa041588
    33 https://doi.org/10.1056/nejmoa1510764
    34 https://doi.org/10.1093/annonc/mdv221
    35 https://doi.org/10.1200/jco.2005.04.7985
    36 https://doi.org/10.1200/jco.2009.24.4798
    37 https://doi.org/10.1200/jco.2011.35.3714
    38 https://doi.org/10.1200/jco.2017.74.0472
    39 schema:datePublished 2018-02
    40 schema:datePublishedReg 2018-02-01
    41 schema:description PURPOSE: Oncotype DX, a gene expression assay widely employed to aid decision making on adjuvant chemotherapy use in patients with primary oestrogen receptor-positive (ER+) breast cancer, produces a recurrence score (RS) related to distant disease recurrence (DR) risk (RS%). In node-negative patients, RS can be integrated with clinicopathological parameters to derive RS-pathology-clinical (RSPC) that improves prognostic accuracy. METHODS: Data were collected on patients having clinically indicated tests with an intermediate clinical risk of distant recurrence, and for whom the decision to prescribe chemotherapy remained unclear. Correlation between RS% and RSPC scores was examined. An agreement table was constructed using risk-categorised data. Association between RS%-derived categorical risk assignments and treatment recommendation was evaluated. RESULTS: Data on 171 tests (168 patients) were available. Median DR risk by RS% was 11% (range 3-34%), by RSPC it was 15% (range 4-63%). Correlation between RS% and RSPC was 0.702 (p < 0.001). RS% classified 57.3% of cases as low-, 32.2% intermediate- and 10.5% high-risk for DR; by RSPC proportions were 33.9, 35.7, and 30.4%, respectively. The number of patients receiving chemotherapy recommendations was: 14/87 (16.1%) categorised as low-risk by RS%, 27/49 (55.1%) as intermediate-risk and 12/13 (92.3%) as high-risk. Of 149 patients recommended for endocrine treatment alone, 28 (18.8%) were categorised by RS% as low-risk but by RSPC as intermediate- or high-risk. CONCLUSIONS: In this group of patients, RSPC assessed fewer patients as low-risk and more as high-risk than did RS%. The discordances between the scores indicate that RSPC estimates of risk should be considered when selecting patients for endocrine therapy alone.
    42 schema:genre research_article
    43 schema:inLanguage en
    44 schema:isAccessibleForFree true
    45 schema:isPartOf N36c6b0df6ddf49f79a7ee6dcf30998d7
    46 Na0135fe694ca41469b33044986a37233
    47 sg:journal.1092777
    48 schema:name Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
    49 schema:pagination 249-258
    50 schema:productId N46e568464c5045fd8802223720a9340c
    51 N8c9d8ba520e4400ebec5f575d5e5b299
    52 Nb72f328d21a8461a8394e1d8a8621b0f
    53 Nd8561e6326f547b8a24611735fd64bdf
    54 Nffc40c443cac40a38d69c5c23ee266e4
    55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092649506
    56 https://doi.org/10.1007/s10549-017-4514-z
    57 schema:sdDatePublished 2019-04-11T12:23
    58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    59 schema:sdPublisher N521767d965a141eda2aa83b8e788fac7
    60 schema:url https://link.springer.com/10.1007%2Fs10549-017-4514-z
    61 sgo:license sg:explorer/license/
    62 sgo:sdDataset articles
    63 rdf:type schema:ScholarlyArticle
    64 N000e9de1a36e45adb827a456419f1925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    65 schema:name Breast Neoplasms
    66 rdf:type schema:DefinedTerm
    67 N091daea448504a12bd2dafc6985f9372 rdf:first sg:person.010725012037.63
    68 rdf:rest Neccd46a8153d4d9eadd68e5b0b8d1a00
    69 N0ddb03abfc4243e190998ab598f18761 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    70 schema:name Genetic Testing
    71 rdf:type schema:DefinedTerm
    72 N145be29eaa2b4ebf8c60241438ebf484 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    73 schema:name Patient Selection
    74 rdf:type schema:DefinedTerm
    75 N15f52172400448e0bdca22e07dde36ba rdf:first sg:person.015776405257.84
    76 rdf:rest rdf:nil
    77 N221bff9ac07a413f8f7c3398f1dffe68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    78 schema:name Gene Expression Profiling
    79 rdf:type schema:DefinedTerm
    80 N314ae4b124a545bfad6383ba3d520c4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    81 schema:name Prognosis
    82 rdf:type schema:DefinedTerm
    83 N36c6b0df6ddf49f79a7ee6dcf30998d7 schema:volumeNumber 168
    84 rdf:type schema:PublicationVolume
    85 N389ff044fa2c4d13ab4e15c069135fd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    86 schema:name Incidence
    87 rdf:type schema:DefinedTerm
    88 N3b032b0b42a64f779f1412792ff9f0aa rdf:first sg:person.011612374617.40
    89 rdf:rest N7505ed32f732437d9a9b48e66600102d
    90 N464edc2459034a779eb7664f8690397e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Aged
    92 rdf:type schema:DefinedTerm
    93 N46e568464c5045fd8802223720a9340c schema:name readcube_id
    94 schema:value d5109efecab0f6c40db614ced9de37ad6fb89c4d8c88b96b5f0eab2243002ac4
    95 rdf:type schema:PropertyValue
    96 N4f37cc5d091f471c850f447da5eebaf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Receptors, Estrogen
    98 rdf:type schema:DefinedTerm
    99 N521767d965a141eda2aa83b8e788fac7 schema:name Springer Nature - SN SciGraph project
    100 rdf:type schema:Organization
    101 N6a71070520e74875bb397b004e7f50ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Humans
    103 rdf:type schema:DefinedTerm
    104 N6b5e3279dea04451ad4116f2bce1a711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Chemotherapy, Adjuvant
    106 rdf:type schema:DefinedTerm
    107 N6f98f305661b48b691f89616e2879664 rdf:first sg:person.0735065012.30
    108 rdf:rest N15f52172400448e0bdca22e07dde36ba
    109 N74d7bad7742c471f8db4c5934d631ae0 rdf:first sg:person.012110012351.30
    110 rdf:rest Na85c5ec324c04f68a2d1f9c363c7820a
    111 N7505ed32f732437d9a9b48e66600102d rdf:first sg:person.0775270405.05
    112 rdf:rest N74d7bad7742c471f8db4c5934d631ae0
    113 N85a77888f9eb4b5eb9498a907344102d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Mastectomy
    115 rdf:type schema:DefinedTerm
    116 N87cb59c54758466c8ce94b6594dabe3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Adult
    118 rdf:type schema:DefinedTerm
    119 N8c9d8ba520e4400ebec5f575d5e5b299 schema:name dimensions_id
    120 schema:value pub.1092649506
    121 rdf:type schema:PropertyValue
    122 N946afd739d8443e5a9d7475eca42a17f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Antineoplastic Agents, Hormonal
    124 rdf:type schema:DefinedTerm
    125 N98a3488a7d3748e1aedbed63167790b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Predictive Value of Tests
    127 rdf:type schema:DefinedTerm
    128 N9db29da632c04d198c9484d26a4f1c66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Risk Assessment
    130 rdf:type schema:DefinedTerm
    131 N9f7e4091bc614df58dc69523584d4b72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Breast
    133 rdf:type schema:DefinedTerm
    134 Na0135fe694ca41469b33044986a37233 schema:issueNumber 1
    135 rdf:type schema:PublicationIssue
    136 Na1ed3dfa373346b390c0aa20957bdd2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Breast Neoplasms, Male
    138 rdf:type schema:DefinedTerm
    139 Na85c5ec324c04f68a2d1f9c363c7820a rdf:first sg:person.016301514162.37
    140 rdf:rest N6f98f305661b48b691f89616e2879664
    141 Nb373b4fccd2b43119d7de548832e683b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Male
    143 rdf:type schema:DefinedTerm
    144 Nb72f328d21a8461a8394e1d8a8621b0f schema:name nlm_unique_id
    145 schema:value 8111104
    146 rdf:type schema:PropertyValue
    147 Nb76cfaeef7cc45edb0dbb6c1b64c038f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Female
    149 rdf:type schema:DefinedTerm
    150 Nc86a3a291ba942f38d4b98f05b4e8f4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Middle Aged
    152 rdf:type schema:DefinedTerm
    153 Nd8561e6326f547b8a24611735fd64bdf schema:name doi
    154 schema:value 10.1007/s10549-017-4514-z
    155 rdf:type schema:PropertyValue
    156 Ne254aff17e31419e861bba97e8ca7c08 rdf:first sg:person.0627311067.49
    157 rdf:rest N091daea448504a12bd2dafc6985f9372
    158 Neccd46a8153d4d9eadd68e5b0b8d1a00 rdf:first sg:person.0605365262.60
    159 rdf:rest N3b032b0b42a64f779f1412792ff9f0aa
    160 Nfa564d6a22b6419881102e9884b2a952 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name United Kingdom
    162 rdf:type schema:DefinedTerm
    163 Nff22ef2194cf489b9d9ef945970663de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Neoplasm Recurrence, Local
    165 rdf:type schema:DefinedTerm
    166 Nffc40c443cac40a38d69c5c23ee266e4 schema:name pubmed_id
    167 schema:value 29128896
    168 rdf:type schema:PropertyValue
    169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    170 schema:name Medical and Health Sciences
    171 rdf:type schema:DefinedTerm
    172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Oncology and Carcinogenesis
    174 rdf:type schema:DefinedTerm
    175 sg:journal.1092777 schema:issn 0167-6806
    176 1573-7217
    177 schema:name Breast Cancer Research and Treatment
    178 rdf:type schema:Periodical
    179 sg:person.010725012037.63 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
    180 schema:familyName Okonji
    181 schema:givenName David
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725012037.63
    183 rdf:type schema:Person
    184 sg:person.011612374617.40 schema:affiliation https://www.grid.ac/institutes/grid.451052.7
    185 schema:familyName Rigg
    186 schema:givenName Anne
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011612374617.40
    188 rdf:type schema:Person
    189 sg:person.012110012351.30 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
    190 schema:familyName Turner
    191 schema:givenName Nick
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012110012351.30
    193 rdf:type schema:Person
    194 sg:person.015776405257.84 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
    195 schema:familyName Dowsett
    196 schema:givenName Mitch
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015776405257.84
    198 rdf:type schema:Person
    199 sg:person.016301514162.37 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
    200 schema:familyName Smith
    201 schema:givenName Ian
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016301514162.37
    203 rdf:type schema:Person
    204 sg:person.0605365262.60 schema:affiliation https://www.grid.ac/institutes/grid.451349.e
    205 schema:familyName Assersohn
    206 schema:givenName Laura
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605365262.60
    208 rdf:type schema:Person
    209 sg:person.0627311067.49 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
    210 schema:familyName Dodson
    211 schema:givenName Andrew
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627311067.49
    213 rdf:type schema:Person
    214 sg:person.0735065012.30 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
    215 schema:familyName Parton
    216 schema:givenName Marina
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735065012.30
    218 rdf:type schema:Person
    219 sg:person.0775270405.05 schema:affiliation https://www.grid.ac/institutes/grid.426108.9
    220 schema:familyName Sheri
    221 schema:givenName Amna
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775270405.05
    223 rdf:type schema:Person
    224 sg:pub.10.1038/bjc.1987.230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047698959
    225 https://doi.org/10.1038/bjc.1987.230
    226 rdf:type schema:CreativeWork
    227 https://app.dimensions.ai/details/publication/pub.1080732988 schema:CreativeWork
    228 https://doi.org/10.1016/j.clbc.2015.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049693612
    229 rdf:type schema:CreativeWork
    230 https://doi.org/10.1016/s0140-6736(11)61625-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016340431
    231 rdf:type schema:CreativeWork
    232 https://doi.org/10.1016/s0140-6736(14)61396-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046101168
    233 rdf:type schema:CreativeWork
    234 https://doi.org/10.1016/s1470-2045(09)70314-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011515750
    235 rdf:type schema:CreativeWork
    236 https://doi.org/10.1056/nejmoa041588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022156409
    237 rdf:type schema:CreativeWork
    238 https://doi.org/10.1056/nejmoa1510764 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036616787
    239 rdf:type schema:CreativeWork
    240 https://doi.org/10.1093/annonc/mdv221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036102989
    241 rdf:type schema:CreativeWork
    242 https://doi.org/10.1200/jco.2005.04.7985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011750427
    243 rdf:type schema:CreativeWork
    244 https://doi.org/10.1200/jco.2009.24.4798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000489684
    245 rdf:type schema:CreativeWork
    246 https://doi.org/10.1200/jco.2011.35.3714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049665380
    247 rdf:type schema:CreativeWork
    248 https://doi.org/10.1200/jco.2017.74.0472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090577469
    249 rdf:type schema:CreativeWork
    250 https://www.grid.ac/institutes/grid.18886.3f schema:alternateName Institute of Cancer Research
    251 schema:name Institute of Cancer Research, 123 Old Brompton Road, SW7 3RP, London, UK
    252 Ralph Lauren Centre for Breast Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK
    253 rdf:type schema:Organization
    254 https://www.grid.ac/institutes/grid.426108.9 schema:alternateName Royal Free Hospital
    255 schema:name Royal Free London Hospitals NHS Foundation Trust, London, UK
    256 rdf:type schema:Organization
    257 https://www.grid.ac/institutes/grid.451052.7 schema:alternateName National Health Service
    258 schema:name Guy’s and St Thomas’ Hospitals NHS Foundation Trust, London, UK
    259 rdf:type schema:Organization
    260 https://www.grid.ac/institutes/grid.451349.e schema:alternateName St George’s University Hospitals NHS Foundation Trust
    261 schema:name St George’s University Hospitals NHS Foundation Trust, London, UK
    262 rdf:type schema:Organization
    263 https://www.grid.ac/institutes/grid.5072.0 schema:alternateName Royal Marsden NHS Foundation Trust
    264 schema:name Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, SW3 6JJ, London, UK
    265 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...